Filing Details

Accession Number:
0000899243-17-011670
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-03 17:13:15
Reporting Period:
2017-05-01
Filing Date:
2017-05-03
Accepted Time:
2017-05-03 17:13:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520697 Acadia Healthcare Company Inc. ACHC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1448040 Morgan Ronald Fincher 6100 Tower Circle, Suite 1000
Franklin TN 37067
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-02 7,591 $15.96 137,204 No 4 M Direct
Common Stock Acquisiton 2017-05-02 13,350 $29.39 150,554 No 4 M Direct
Common Stock Disposition 2017-05-02 41,483 $44.94 109,071 No 4 S Direct
Common Stock Disposition 2017-05-01 45,000 $43.96 41,135 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2017-05-02 7,591 $0.00 7,591 $15.96
Common Stock Stock Option Disposition 2017-05-02 13,350 $0.00 13,350 $29.39
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-03-19 2022-03-19 No 4 M Direct
0 2017-03-29 2023-03-29 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.67 to $45.45, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.89 to $44.03, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Mr. Fincher expressly disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
  4. By the Ras W. Fincher II Trust u/a/d 09/13/2011, the Morgan M. Fincher Trust u/a/d 09/13/2011 and the Cody C. Fincher Trust u/a/d 09/13/2011.
  5. Options vested on March 29, 2016 and March 29, 2017.